Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Kedudukan dalam Saham #31190
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Harga Saham
$0.03808538
Modal Pasaran
$14.04M
Perubahan (1 hari)
-3.57%
Perubahan (1 tahun)
6.63%
Negara
AU
Perdagangan BCAL Diagnostics Limited (BDX)

Kategori

Sejarah pecahan saham untuk BCAL Diagnostics Limited (BDX)
Saham BCAL Diagnostics Limited (simbol: BDX) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 18, 2026.
Satu saham BDX yang dibeli sebelum Aug 18, 2026 kini bersamaan dengan 0 saham BDX.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US